CSS LLC’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

CSS LLC’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-28,389	Closed	-$7K	–	1211
2022 Q2	$7K	Hold	28,389	–	–	﹤0.01%	1047
2022 Q1	$12K	Sell	28,389 -10,500	-27%	-$5.34K	﹤0.01%	1100
2021 Q4	$34K	Buy	38,889 +13,889	+56%	+$17.5K	﹤0.01%	1128
2021 Q3	$40K	Sell	25,000 -39,564	-61%	-$48K	﹤0.01%	1086
2021 Q2	$65K	Buy	+64,564	New	+$52.2K	﹤0.01%	971

Other funds holding EFTRW

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

ECM

Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return

ICM

III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

CSS LLC's EFTRW Position: Q3 2022 in Review

CSS LLC sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2022, closing a stake of 28,389 shares — an estimated $7K sold.

CSS LLC first reported a position in EFTRW in Q2 2021 and held it in 5 quarters. The position peaked at $65K in Q2 2021. 12 funds tracked by Wall St. Rank hold EFTRW as of Q3 2022.

CSS LLC reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
CSS LLC sold 28,389 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2022, an estimated $7K.
CSS LLC first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q2 2021 and held it in 5 quarters.
CSS LLC's eFFECTOR Therapeutics, Inc. Warrant position peaked at $65K in Q2 2021.
12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.